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 Complexes of nifedipine with β-cyclodextrin and aspartic acid were prepared  
 Multicomponent complex formation increase the aqueous solubility of nifedipine 
 Complexation showed an improvement of the dissolution profile of the drug 
 Nifedipine inserted its aromatic ring into the β-cyclodextrin cavity  




The purpose of this work was to characterize complexes of nifedipine with β-cyclodextrin (β-













profile of nifedipine. Complexes were characterized using infrared spectroscopy, 
thermoanalytical methods, powder X-Ray diffraction, scanning electron microscopy, phase 
solubility analysis and dissolution studies. Spatial configurations were determined by NMR 
and further examined using computational techniques. This investigation showed that the 
amino acid Asp was the most efficient auxiliary agent for multicomponent complexes. The 
spatial configurations were consistent with those obtained by molecular modelling; 
evidencing that nifedipine inserted its aromatic ring into β-CD, in all complexes, with Asp 
interacting with the wide hydrophilic rim of β-CD. The dissolution rates of nifedipine:β-
CD:Asp complexes were significantly increased compared to those of the pure drug or 
nifedipine:β-CD. These results indicate that the nifedipine:β-CD:Asp system is a promising 
approach for the preparation of optimized formulations of nifedipine. 
 
















Enhancing the solubility of poorly water-soluble drugs is one of the most important objectives 
of the pharmaceutical industry, since limited water solubility is generally associated with 
suboptimal dissolution profiles and thus poor oral bioavailability (Göke et al., 2018; 
Kawabata, Wada, Nakatani, Yamada & Onoue, 2011). This is the case of nifedipine (NIF, 
Fig. 1A), a calcium-channel blocking agent widely used in the treatment of angina pectoris 
and hypertension. NIF is classified as a class II substance in the biopharmaceutical 
classification system (BCS), exhibiting poor water solubility while presenting a high 
permeability. Its pharmacokinetic parameters following oral administration are dependent on 
the type of dosage form used (Gajendran et al., 2015; Mercuri, Fares, Bresciani & Fotaki, 
2016). A very important challenge for researchers is to develop new drug delivery systems 
in order to increase the solubility and dissolution rate of class II BCS drugs, such as NIF, 
with the aim of improving dissolution rate profiles leading to enhanced intestinal absorption 
and the corresponding increased bioavailability. 
 
Figure 1. Molecular structure and NMR signal notation of: (A) NIF, (B) β-CD and (C) ASP.  
 
Cyclodextrins (CDs) are cyclic oligosaccharides, widely used in pharmaceutical formulations 
to enhance the solubility, dissolution rate and bioavailability of drugs. Their truncated cone 













and thus efficiently forms inclusion complexes. In the absence of a guest molecule, water 
molecules from the bulk solution occupy the interior cavity of CDs, thus desolvation events 
are required prior to ligand inclusion. In addition, as the exterior rims of CDs contain several 
hydroxyl groups, additional electrostatic interactions with these groups are also possible 
upon ligand binding. Three types of natural CDs are frequently used in the pharmaceutical 
industry, namely α-, β- and γ-CD, containing six, seven or eight (α-1-4)-linked D-
glucopyranoside units, respectively (Iacovino et al., 2017; Muankaew & Loftsson, 2018; 
Narayanan, Boy, Gupta & Tonelli, 2017). Among them, β-CD (Fig. 1B) is the most widely 
used CD, mostly because of the size of its cavity, which is appropriate for the inclusion of a 
vast number of therapeutically relevant drugs. In addition, β-CD is the cheapest among 
natural CDs, which is also a significant advantage in the context of bulk material 
preparations. In previous works, different researchers have investigated the complexation 
of NIF with CDs, with the aim of overcoming the limitations related to its poor water solubility 
(Acartürk, Kişlal & Çelebi, 1992; Bayomi, Abanumay & Al-Angary, 2002; Chutimaworapan, 
Ritthidej, Yonemochi, Oguchi & Yamamoto, 2000; de Araújo et al., 2017; Filipović-Grčić, 
Bećirević-Laćan, Skalko & Jalšenjak, 1996; Heydari, Iranmanesh, Doostan & Sheibani, 
2015; Jagdale, Jadhav, Chabukswar & Kuchekar, 2012; Nikolić et al., 2010; Škalko, Brandl, 
Bećirević-Laćan, Filipović-Grčić & Jalšenjak, 1996; Uekama, Ikegami, Wang, Horiuchi & 
Hirayama, 1992). Although some of these results can be considered promising, in terms of 
biopharmaceutical performance, Beig et al. observed a decrease in the apparent intestinal 
permeability of NIF, as a function of increasing CD concentrations (Beig, Miller & Dahan, 
2013), a feature that may limit the biopharmaceutical performance of the binary system. 
Several studies carried out by different research groups have established that solubilization 
and complexation efficiency of CDs can be improved by forming multicomponent complexes, 
using auxiliary substances, such as polymers, amino acids or hydroxypropylacids (Aiassa, 













al., 2014; Vieira et al., 2015). This strategy is of particular interest applied towards enhancing 
NIF bioavailability, since it allows the use of lower doses of CDs to reach the desired 
solubilizing effect compared to binary systems. The design of these kinds of multicomponent 
systems is very promising since they allow formulation costs to diminish while avoiding CD 
concentration dependent effects (Loftsson & Brewster, 2012). 
In this work, we hypothesize that the preparation of multicomponent supramolecular 
systems of NIF with β-CD and essential amino acids (AAs) may be able to enhance the 
water solubility and dissolution rate of the drug in a greater extent, compared to that of the 
binary complex. In this way, different amino acids were screened with respect to their effect 
in NIF solubility, as a measure of their utility as auxiliary agents. The multicomponent system 
with the most efficient AA was prepared and studied in detail, including phase solubility 
analyses, infrared spectroscopy, thermoanalytical methods, powder X-Ray diffraction and 
scanning electron microscopy. To further, characterize the multicomponent systems at an 
atomic level, molecular docking and dynamics studies were carried out, along with combined 
free-energy of binding analyses. Computational findings were consistent with experimental 
results, finding agreement between spectroscopic (1H NMR) data and the predicted three 
dimensional structures of the binary and multicomponent complexes. Furthermore, empirical 
affinity parameters and binding energies were calculated to investigate the stability of all the 
prepared complexes. 
 
2. MATERIALS AND METHODS 
2.1. Materials 
Nifedipine (98.7%) and glycine (98%) were purchased from Parafarm. β-CD (MW: 1135 
g/mol) was kindly donated by Roquette (agent of Roquette in Argentina); arginine (98%), 
histidine (99%) and leucine (98%) were purchased from Sigma-Aldrich; aspartic acid 













obtained from Merck, while water intended for all analyses was obtained from a Millipore 
Milli-Q water purification system.  
 
2.2. Selection of Auxiliary Agents 
A series of amino acids were screened with NIF to select the appropriate auxiliary agent to 
prepare multicomponent complexes. Experiments were carried out at 37 °C in stoppered 
glass tubes containing an excess amount of NIF (10 mg), with addition of 3 mL of aqueous 
solutions containing a fixed concentration (5mM) of the following amino acids: arginine (Arg), 
aspartic acid (Asp), glycine (Gly), histidine (His) and leucine (Leu). All suspensions were 
shaken on a vortex for 15 seconds and placed in a thermostatic bath at 37.0 ± 0.1 °C to 
reach solubilization equilibria protected from light. Prior to quantification, the samples were 
filtered using a membrane of 0.45 μm (Millipore, USA) in vials. Quantitative determinations 
of NIF were performed using an Agilent S1100 High Performance Liquid Chromatography 
(HPLC) system, equipped with a Phenomenex C8 (4.6 x 250 mm and 5 µm) column at 25°C. 
The mobile phase was methanol:water (60:40), at a flow rate at 1mL/min. Analyte signals 
were obtained using an UV detector set at 238 nm. 
 
2.3. Phase solubility analysis 
The effect of β-CD on the solubility of NIF was studied in triplicate, in the presence and 
absence of the corresponding amino acids. Excess amounts of NIF (10 mg) were added in 
stoppered glass tubes containing water solutions with a fixed concentration of the auxiliary 
agent (5mM) and different amounts of β-CD (0–12.4 mM). Samples were shaken on a vortex 
for 15 seconds and then placed in a thermostatic bath at 37.0 ± 0.1 °C to reach solubilization 
equilibria, protected from light. Prior to quantitation through HPLC, samples were filtered 
with a membrane of 0.45 μm pore diameter (Millipore, USA) in vials and analysed by HPLC. 













the concentration of solubilized NIF versus β-CD concentration in the sample. The stability 
constants (KC) of the complexes were calculated, considering the saturation solubility of NIF 
(S0) in water in the absence of β-CD (for the binary complex) or β-CD and AA (for the 
multicomponent complex). The KC was calculated from the slope of the phase solubility 
diagrams (Eq. 1): 
KC= slope / S0 (1- slope) (Eq. 1) 
2.4.  Molecular modelling  
Initial structures: the structure of β-CD was obtained from the Cambridge Structural 
Database (code BCDEXD10), while those of the corresponding ligands were constructed 
from their SMILES nomenclature, using the MarvinSketch software (MarvinSketch, 2017). 
Prior to docking assays, the three-dimensional structures of the ligands were energy 
minimized by applying a semiempirical method as implemented in the software Gaussian09 
(Frisch et al., 2009). 
Molecular docking studies: in order to perform these studies, the Autodock4 software was 
used (Morris et al., 2009). In all docking procedures, a docking grid was precomputed using 
the Autogrid4 software, setting a docking grid positioned in the centre of mass of β-CD, and 
extending 22 Å in the x,y,z direction. The charges corresponding to β-CD were assigned 
from the Glycam06 force field (Kirschner et al., 2008), while those for the ligand were 
assigned from the GAFF forcefield (Wang, Wolf, Caldwell, Kollman & Case, 2004). Docking 
runs were performed considering a rigid receptor (i.e. β-CD) and a flexible ligand, with the 
corresponding conformations generated using a Lamarckian Genetic Algorithm applying the 
default search parameters implemented in the software. To exhaustively analyse the 
resulting docked poses, a representative member of each cluster of conformations obtained 
from the docking runs was subjected to further analysis by molecular dynamics (MD), both 













starting structure of the corresponding binary complex was generated from a cluster analysis 
applied over the molecular dynamics trajectories obtained for each NIF binding mode. As 
was performed for the binary system, to identify the most stable binding mode of the auxiliary 
agent, all alternate binding modes were subjected to MD analysis and free energy of binding 
analysis. 
Molecular Dynamics simulations: The Amber18 software was used (Case et al., 2018), using 
explicit solvent conditions to obtain each trajectory. Starting structures corresponding to 
either the binary or multicomponent complex were parameterized using the tleap module of 
Amber18 (Case et al., 2018), applying the corresponding parameters form the Glycam06 
and GAFF forcefields for the host and guest molecules, respectively (Kirschner et al., 2008; 
Wang, Wolf, Caldwell, Kollman & Case, 2004). Complexes were solvated using a pre-
equilibrated TIP3P explicit water model, applying a solvent box with boundaries at a 
minimum distance from the solute of 10 Å in each direction. After standard minimization 
procedures (5000 steps, first stage: solute restrained; 5000 steps, second stage: 
unrestrained system), the minimized complexes were heated under constant volume 
conditions from 0 to 300 K in a 0.5 ns timeframe, applying restraints on the solute. Next, the 
complexes were equilibrated during 1 ns, after which the production phase under constant 
pressure and temperature conditions was performed for an additional 10 ns. In all cases, a 
2 fs timestep was used, with the SHAKE algorithm applied to constrain all covalent bonds 
involving hydrogen atoms. A 10 Å cutoff value was used to calculate non-bonded 
interactions. In addition, MD simulations were also studied using DMSO as explicit solvent. 
To develop the solvent system, DMSO charges were calculated using ab-initio methods as 
implemented in the Gaussian 09 software (Frisch et al., 2009), after which a 60 Å DMSO 
cubic box was constructed using the Packmol software (Martínez, Andrade, Birgin & 
Martínez, 2009). The corresponding box of solvent was pre-equilibrated at 300K applying 













value for DMSO was reached (1.1 g/cm3). Periodic boundary properties were assigned to 
the developed DMSO box in order to simulate the corresponding systems. 
MD trajectories were generated using CUDA designed code (pmemd.cuda), and computed 
using computational resources provided by the CCAD – Universidad Nacional de Córdoba 
(http://ccad.unc.edu.ar/). In particular, the Mendieta cluster was used, which is part of 
SNCAD – MinCyT, República Argentina. 
Energetic interaction studies: The Molecular Mechanics Generalized Born Surface Area 
technique (Miller, McGee, Swails, Homeyer, Gohlke & Roitberg, 2012) was used to calculate 
the interaction energies corresponding to molecular docking poses and MD trajectories 
obtained for each binding mode and cluster of conformations.  
Analysis and visualization: MD trajectories were displayed using the VMD software 
(Humphrey, Dalke & Schulten, 1996) and were analysed with CPPTRAJ module of 
Amber18. Some specific processes were performed using in-house developed scripts. 
2.5. Nuclear Magnetic Resonance spectroscopy (1H NMR) 
The 1HNMR studies were carried out to characterize the interaction mechanism of NIF with 
both β-CD and Asp. All NMR spectra were collected using a BrukerAvance II High 
Resolution spectrometer at 400.16 MHz. Samples were dissolved in DMSO-d6. Induced 
changes in the 1H chemical shifts of NIF, β-CD and AA, originated due to their complexation, 
were calculated using equation 2: 
∆δ = δcomplex - δfree (Eq. 2) 
 
2.6. Preparation of systems in the solid state 
Binary (NIF:β-CD) and multicomponent systems (NIF:β-CD:AA) were prepared by two 













Physical Mixing (PM): binary and multicomponent systems were prepared employing 1:1 
molar ratio of NIF:β-CD and 1:1:1 molar ratio of NIF:β-CD:AA. Both preparations were mixed 
in an agate mortar for 5 min and were stored in glass vials protected from light. 
Kneading (KN): NIF, β-CD and AA with 1:1 and 1:1:1 molar ratio were accurately weighed 
and transferred to a mortar, adding 0.25 µL of a methanol:water (1:1vol./vol.) mixture  per 
mg of solid and the mixture was kneaded in a mortar for 30 min until an homogenous paste 
was formed. In addition, pure NIF was processed following the same protocol for 
comparative purposes. All samples were stored in glass vials protected from light. 
 
2.7. Infrared Spectroscopy (IR) 
The IR spectra of pure compounds, binary and multicomponent systems (both obtained by 
physical mixtures and kneading) were recorded on a Nicolet Avatar 360 FTIR spectrometer 
in the range of 4000-400 cm-1.  
 
2.8. Differential Scanning Calorimetry  and Thermogravimetry 
Differential scanning calorimeter (DSC) tests were recorded on a DSC Discovery series 
instrument (TA, USA) and thermogravimetric (TG) tests of samples were recorded on a TG 
Discovery series instrument (TA, USA). The thermal behaviour was studied by heating 1-2 
mg of the samples in perforated aluminium capsules under nitrogen atmosphere, scanning 
a temperature range between 25-200°C (DSC) and 25-350°C (TG), applying a heating rate 
of 10°C min-1. The relative degree of drug crystallinity (RDC) in the complexes was 
calculated using equation 3: 
RDC =  
∆𝐻𝑐𝑜𝑚𝑝𝑙𝑒𝑥
∆𝐻𝑑𝑟𝑢𝑔
 𝑥 100 (Eq. 3) 
Where ΔHcomplex correspond to the fusion enthalpy of NIF in the complex and ΔHdrug 














2.9. Powder X-Ray Diffraction (PXRD) 
The PXRD patterns were recorded at room temperature on a PANanalitycal X’Pert PRO 
diffractometer with Cu-Kα radiation. The PXRD data were collected by scanning 2θ from 4° 
to 35° with a step size of 0.026° at a scanning rate of 23.0 s/step.  
 
2.10.  Scanning Electron Microscopy (SEM) 
The SEM microphotographs were collected using a Carl Zeiss Σigma microscope at the 
Laboratorio de Microscopía y Análisis por Rayos X (LAMARX) of the Universidad Nacional 
de Córdoba, Argentina. The samples were fixed on a brass stub using double-sided 
aluminium tape, which were then made electrically conductive by coating in gold under 
vacuum using a Quorum 150 sputter coater. 
 
2.11. Dissolution study 
To investigate the effect of complexation of NIF on its dissolution behaviour, studies were 
performed using a dissolution apparatus (Hanson SRII6 Flask Dissolution Test Station, 
Hanson Research Corporation, Chatsworth, USA). Assays were carried out using an 
equivalent of 10 mg of NIF (in powder state) and 900 mL of simulated gastric fluid, free of 
enzymes (pH 1.2). The dissolution medium was maintained at 37.0 ± 0.5 °C and stirred at 
50 rpm. Aliquots (2 mL) were collected at predetermined time intervals and filtered using 
0.45 μm pore diameter membranes (Millipore, USA). Equal volumes of pre-warmed fresh 
dissolution medium were used to replace the volume corresponding to withdrawn samples. 
The filtered sample solutions were analysed using a UV spectrophotometer (Shimadzu, UV-
Mini 1240) set at 238 nm, with the percent release of drug calculated. Comparison of the 
corresponding dissolution profiles (i.e. of pure NIF and the corresponding supramolecular 













factor (Eq. 4). The profiles were considered similar when a resulting f2 value was equal or 
higher to 50. 






2]−0,5} 𝑥 100       (Eq. 4) 
where n is the number of sampling points, Rt is the percentage dissolved of the reference 
sample (pure NIF) at each time point t, and Tt is the percentage dissolved of the studied 
system (supramolecular systems) at each time point t. 
 
3. RESULTS AND DISCUSSION  
3.1. Selection of auxiliary agents 
The first stage of this study involved the screening and selection of the auxiliary agent (i.e. 
amino acid) able to produce the greatest enhancement of solubility. With this aim, the NIF 
solubility enhancement effect of five different AAs (Arg, Asp, Gly, His and Leu) was 
analysed, with the corresponding final pH of the solution being measured. The results of 
these studies are presented in Fig. 2A and Table 1, where the maximum NIF solubility values 
obtained in the presence of different AAs are shown. As depicted in Fig. 2A, the solubility of 
pure NIF increased in the presence of all AAs screened. As expected, the pH value of the 
resulting solution was different for each AA tested, with some of them eliciting almost no 
modification of pH value with respect to the pure NIF solution (Asp), some produced a 
moderate increase in the pH value (Gly and Leu ) and others produced a marked increase 
in the resulting pH (Arg and His). It should be mentioned that both Arg and His induced an 
increase in the degradation rate of NIF, a fact that may be related to the relatively instability 
of ester compounds at higher pH values. As can be seen in Figure 2A, Asp produced the 
highest increase in NIF solubility among the entire set of auxiliary agents screened, 













Consequently, Asp was selected as the most promising auxiliary agent for the preparation 
of multicomponent systems containing NIF, β-CD and AA. 
 
 
Figure 2. (A) NIF solubility in the presence of different auxiliary substances. (B) Phase 
solubility analysis of the binary (NIF:β-CD ●) and multicomponent (NIF:β-CD:Asp ■) 
systems. 
 
3.2. Phase solubility analysis 
To further study the possibility of enhancing NIF solubility by preparation of binary or 
multicomponent systems, complexes containing β-CD, NIF and ASP were prepared, with 
the corresponding  phase-solubility diagrams (PSD) being determined for the NIF:β-CD 
complex in the presence and absence of Asp (5 mM). The corresponding results are 
presented in Figure 2B.The results demonstrate that the solubility of NIF increased in a 
linear mode, both in the binary (NIF:β-CD) and the multicomponent (NIF:β-CD:Asp) 
systems, and thus corresponded to the type AL profile established by Higuchi and Connors 
(Higuchi & Connors, 1965), which is related to the formation of a soluble inclusion complex. 













complex with 1:1 stoichiometry in the presence and absence of auxiliary agent. The 
corresponding affinity constant (KC), maximum solubility (Smax) and efficiency of solubility 
(ES, Smax/S0) values were calculated from each PSD and are presented in Table 1.The 
multicomponent system with ASP showed a KC and ES value higher than that of the binary 
system. This result demonstrates cooperativity in the interaction between NIF and β-CD in 
the presence of Asp, a phenomenon that favours both the solubilizing and complexing ability 
of β-CD. These observations suggest the formation of a multicomponent complex between 
these substances.  
 
3.3. Molecular modelling of binary and multicomponent complexes  
It has been previously reported that auxiliary agents can increase the aqueous solubility of 
drugs by interacting with the external surface of the drug:CD complexes, and the observed 
solubility enhancement was attributable to the contribution of different interactions (van der 
Waal forces, formation of hydrogen bonds, hydrophobic interactions, dipole−dipole 
electrostatic bonds)(Loftsson & Brewster, 2012). To elucidate the structure of the complexes 
and to gain insight into the intermolecular interactions taking place in solution between NIF, 
β-CD and Asp, we performed detailed molecular modelling studies, including molecular 
docking and molecular dynamics simulations. Taking into account that spectroscopic data 
was obtained using DMSO as solvent and that solubility phase analyses were performed in 
aqueous solutions, in a first stage the agreement between the MD trajectories obtained in 
both solvents was studied. No significant differences in the conformational properties and 
associated interaction energies were found when simulations performed in DMSO or water 
were compared (Table S1, Figures S1 and S2). 
First, molecular docking studies were performed in order to elucidate the lowest energy 
binding mode of NIF to β-CD. Ten different binding modes were obtained, which where 













energies were calculated. Figure 3A presents the lowest energy binding mode, with Table 2 
reporting the corresponding energetic components of interaction. As can be seen, the 
aromatic ring containing the nitro moiety was deeply buried in theβ-CD cavity, with the Van 
der Waals interaction energy as the main driving force for stabilizing the complex. The 
overall interaction energy for the binary complex was -18.7 Kcal/mol. 
Next, the multicomponent system was modelled by docking aspartic acid to the above 
described NIF:β-CD complex. Again, multiple binding modes were obtained, which were 
subjected to explicit solvent MD studies. In order to identify the most stable multicomponent 
system, the affinity interaction energy of NIF with the rest of the system was calculated. 
Figure 3B shows the predicted three dimensional structure of the multicomponent system, 
in which it can be seen that Asp was positioned towards the wide rim of β-CD, between the 
macromolecule and NIF. The resulting complex was subjected to MD analysis, revealing 
that described binding mode of Asp was conserved. The corresponding interaction energies 
for NIF were calculated in the multicomponent system (Table 2). As can be seen, the 
interaction of NIF with the multicomponent system is considerably more stable than that 
observed for the binary complex, originated in both a higher Van der Waals and electrostatic 
interaction. The higher Van der Waals component was mostly derived in a more stable 
buried conformation of the aromatic ring of NIF within the βCD hydrophobic cavity (Figure 
S3). In addition, Asp was able to act as a molecular bridge between NIF and βCD 




























Figure 3. Three-dimensional conformation of the complexes obtained by molecular 
docking. (A) NIF:β-CD and (B) NIF:β-CD:ASP. 
 
 
Regarding the interaction mode of NIF in both systems, it is noteworthy that the nitro group 
is not able to establish hydrogen bond interactions with β-CD, mostly due to an unfavourable 
geometry resulting from the inclusion of the aromatic ring. In addition, and based on 
structural parameters, CH-pi interactions between the aromatic ring of NIF and β-CD are 
feasible (Fig. S5 a-d), although the applied force field does not account for this type of 
interactions. 
 
3.4. Proton Nuclear Magnetic Resonance spectroscopy (1H NMR)  
1H NMR experiments were performed to further investigate the interactions between the 
components in solution and confirm the geometry of the inclusion complexes predicted by 
molecular modelling. The formation of the complexes was evidenced by comparing the 
changes of the chemical shift values (δ) in the 1H NMR spectra of binary (NIF:β-CD) and 














spectra under the same experimental conditions. As can be seen in Table 3 and Fig. S6 (for 
NMR signal notation see Fig. 1), all signals of the compounds suffered – to a greater or 
lesser extent – a variation (Δδ), which allowed us to predict the existence of numerous 
interactions between the molecules that form each complex. 
As can be observed in Table 3, almost all NIF proton resonances were modified, in the 
binary and multicomponent complexes, and exhibited a shielding effect with respect to those 
of the pure drug. The proton Hb and He of NIF showed a major displacement that can be 
attributed to this moiety that was located in a rich electronic density environment (proximate 
to the glycosidic linkage oxygen of β-CD that are rich in π electrons, for example) that 
produced a shielding effect. This mode of inclusion is in good agreement with the molecular 
modelling prediction. In addition, the upfield shift experiments for the other protons of the 
drug may reflect some conformational changes produced by the inclusion.  
When spectra of β-CD were analysed, it was possible to observe a deshielding effect in all 
macromolecules protons. The downfield displacements found for both H3 and H5 protons 
(located in the interior of CD cavity), suggested the insertion of an electronegative moiety of 
the guest into the β-CD hydrophobic cavity, which produced the deshielding effects we 
observed. These findings are in agreement with the results of the theoretical studies that 
suggested the insertion of the aromatic ring containing the nitro group. It is important to note 
the great variation of hydroxyl proton signals (OH2, OH3 and OH6) of β-CD. This allowed us 
to suggest the existence of hydrogen bond interactions with the drug. On the other hand, in 
the multicomponent complex, Asp could also interact with the external surface of β-CD, 
because the protons HII exhibited deshielding effects, which might be explained by the 
presence of hydrogen bond interactions between the amino acid and β-CD. The 
displacement of the protons was more apparent in the NIF:β-CD:Asp multicomponent 













results obtained in the NMR studies are in agreement with the observation of phase solubility 
analysis and with the geometries suggested for the molecular modelling assays.  
 
3.5. Infrared Spectroscopy (FTIR) 
To evaluate any possible interaction of the drug with β-CD and Asp molecules in the solid 
state, the FTIR technique was employed. In Figure S7 the infrared spectra of pure 
compounds as well as NIF:β-CD and NIF:β-CD:Asp systems (both PM and KN) are shown. 
NIF spectra showed peaks at 3330 cm-1 (N-H aromatic), 3101 cm-1 (C-H aromatic), 2952 cm-
1 (C-H aliphatic), 1685 cm-1 (C=O), 1529 cm-1 (NO2), 1495 cm-1 (C=C aromatic) and 1227 cm-
1 (C-C-O ester). Since no new peaks were observed when the FTIR spectra for the binary 
(PM and KN) and multicomponent (PM and KN) systems were compared with those of the 
pure compounds, the formation of covalent interactions was discarded. In addition, no 
important changes were observed in the spectra of either PM (Table 4), since the main 
peaks related to functional groups of the involved substances were maintained. In the case 
of systems prepared by KN, a shift of various absorption bands of NIF was observed, 
compared with the pure drug (Table 4). This would indicate that these functional groups 
could be involved in interactions necessary for the formation of the complexes in solid state. 
 
 
3.6. Differential Scanning Calorimetry (DSC) and Thermogravimetry (TG) 
The thermal properties of the supramolecular systems were evaluated by means of TG and 
DSC, and were compared with the pure compounds. The relative degree of NIF crystallinity 
in systems was calculated based on melting enthalpy. The TG and DSC curves of all 
samples studied are depicted in Figure 4. The DSC and TG curves of pure NIF showed a 
sharp endothermic peak at 173°C, attributable to the melting process of the crystalline form 













important events were observed: the first was an endothermic peak between 50 and 105°C 
(7.6% mass loss) and the second (308°C, 79.9% mass loss) was attributable to dehydration 
and decomposition, respectively. Asp curves showed a single stage of mass loss attributable 
to it degradation at 234 °C. In the analysis of DSC and TG curves of binary and 
multicomponent physical mixtures, no significant changes were observed and the 
crystallinity degree of NIF was not modified. On the other hand, the NIF:β-CD complex, 
prepared by the kneaded method, exhibited a small decrease of drug crystallinity (RDC: 
91%) while the NIF:β-CD:Asp complex showed a substantial reduction of drug crystallinity 
(RDC: 56%), indicating a significant concentration of the drug in its amorphous form, 
reinforcing the multicomponent complex formation. 
 
Figure 4.DSC and TG curves of: NIF (red), β-CD (pink), Asp (purple), NIF:β-CD PM 
system (blue), NIF:β-CD KN system (light blue), NIF:β-CD:Asp PM system (green) and 
NIF:β-CD:Asp KN system (light green). 
 
3.7. Powder X-ray diffraction (PXRD) 
PXRD was employed to study the effect of binary and multicomponent complexation of NIF 
by cyclodextrin on their crystalline structures.  The diffractograms of NIF, βCD, Asp physical 



















patterns of NIF (8.2, 10.5, 11.7, 16.3, 24.4, 26), βCD (10.7, 12.6, 15.5, 17.2, 20.8 and 27.2) 
and Asp (11.8, 21.7, 22.8, 23.4 and 28.2) show intense sharp peaks that indicates a high 
crystallinity. In addition, it was possible to observe the presence of all the characteristic 
peaks of pure compounds in the diffractograms corresponding to the binary and 
multicomponent systems prepared by PM, evidencing that complexation between them did 
not occurred. In contrast, in the NIF:βCD and NIF:βCD:Asp systems obtained by KN, a 
decrease in the crystallinity degree of the compounds was observed, although some 
characteristic peaks of pure NIF were still detectable. The results obtained by PXRD and 
DSC and the observed low crystallinity state of the systems obtained by KN confirms the 
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Figure 5. (A) Powder X-ray diffractograms of: (a) NIF, (b) β-CD, (c) Asp, (d) NIF:β-CD PM 
system (e) NIF:β-CD KN system, (f) NIF:β-CD:Asp PM system and (g) NIF:β-CD:Asp KN 
system. (B) Scanning electron microphotographs of: (a) NIF, (b) β-CD, (c) Asp,  (d) NIF:β-
CD PM system (e) NIF:β-CD KN system, (f) NIF:β-CD:Asp PM system and (g) NIF:β-CD:Asp 
KN system.  
 
 
3.8. Scanning Electron Microscopy (SEM) 
SEM was used to evaluate the morphological characteristics of the individual compounds, 
their physical mixtures and corresponding complexes. The representative SEM images of 
all materials are shown in Figure 5B. In both systems prepared by PM, the size and shape 
of the particles were more varied and irregular than those obtained by the KN method. In 
the NIF:β-CD KN complex, it was possible to observe bulky and dense blocks, while more 
homogenous particle size distribution was observed in the NIF:β-CD:Asp KN complex. 
3.9. Dissolution study 
The dissolution studies were performed for pure NIF, and for both binary and 
multicomponent systems obtained by PM and KN methods with the aim to evaluate the 
effect of complexation on the drug dissolution rate. The results of the dissolution study are 
shown in Figure 6. The study showed 28 ± 2% dissolution of pure NIF in the initial 5 minutes, 
and a maximum of 30 ± 2% drug dissolution at 180 minutes. This poor dissolution of NIF 
can be attributed to the lower solubility of NIF in the dissolution medium. No differences were 
observed when unprocessed drug was compared with the pure drug submitted to the 
kneading process (NIF KN 27.7 ± 0.4% and 39 ± 2%, at 5 and 180 min, respectively, with 
anf2value of 68). Both binary (NIF:β-CD) and multicomponent (NIF:β-CD:Asp) complexes 
significantly improved the dissolution profile of NIF, and the profiles were not similar to that 













< binary PM (f2: 39) < binary KN (f2: 32) < multicomponent PM (f2: 29) < multicomponent KN 
(f2: 22). The percentage of release shown by the systems at 180 minutes was 68 ± 2% 
(binary PM), 66 ± 6% (binary KN), 79 ± 1% (multicomponent PM) and 95.0 ± 0.5% 
(multicomponent KN); which implied an increase of 2.2, 2.2, 2.6 and 3.1 times, respectively. 
The fact that the multicomponent complexes improved the dissolution profile of NIF, not only 
with respect to the pure drug, but also to the binary complexes, confirms the ability of Asp 
to act as an auxiliary agent to permit optimization of drug dissolution behaviour. The 
difference found between the profiles of NIF:β-CD:Asp PM and NIF:β-CD:Asp KN (f2:43) are 
attributable to the fact that the drug is partially amorphized in the NIF:β-CD:Asp KN, as was 







Figure 6. Dissolution profiles of pure NIF (■) and NIF kneading (●), NIF:β-CD physical 
mixture (▲), NIF:β-CD kneading system (▼), NIF:β-CD:Asp physical mixture (◄) and 
NIF:β-CD:Asp kneading system (►). 
 
CONCLUSIONS 
This study shows that the formation of a multicomponent complex between NIF, β-CD and 
Asp was an adequate approach to improve the solubility and dissolution performance of the 












in the β-CD cavity, and the Van der Waals interaction energy was the main driving force for 
the stabilization of the complex. In addition, computational modelling studies revealed that 
Asp increased the stability of the multicomponent complex, which was consistent with the 
experimental finding observed in the phase solubility analysis and 1H NMR studies. The 
observed enhancement in the affinity of NIF in the multicomponent system is originated in a 
more stable inclusion of the aromatic ring of NIF within the βCD cavity, and that results in a 
significantly higher VDW interaction. The auxiliary agent is anchored facing the wide rim of 
βCD in the interface between the host and guest molecules, acting as a bridge for 
electrostatic interaction between them. Changes in shape and size distribution of NIF in the 
multicomponent complex were evident by SEM. In addition, the DSC and PXRD data 
confirmed a greater decrease in the NIF crystallinity in the multicomponent complex, 
compared to the binary one. Although all of the systems studied have improved the 
dissolution rate of NIF, largely, the multicomponent complex was superior to all other 
systems. Therefore, we conclude that the NIF:β-CD:Asp multicomponent complex will be 
valuable to optimize the properties of NIF pharmaceutical formulations. 
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Table 1. Effect of the amino acids and β-CD on NIF solubility. 
System Smax(µg/ml)a ESb KC (M-1) pH 
Arg 6.3 ± 0.2 1.1 - 6.5 
Asp 9.0 ± 0.3 1.5 - 3.9 
Gly 6.5 ± 0.6 1.1 - 5.6 
His 7.1 ± 0.8 1.2 - 6.4 
Leu 7.0 ± 0.2 1.2 - 5.7 
β-CD 13.5 ± 0.2 2.2 99± 2 4.0 
β-CD:Asp 15.0 ± 0.2 2.5 117± 4 4.0 
aSmax, maximum value of solubility measured; bES, efficiency of solubility (Smax/S0),  
S0= 6.06 ± 0.02 µg/ml.  
 
Table 2.  Total Interaction energy (ΔE global) and corresponding components (VDW, Van 
der Waals energy; EEL, electrostatic energy; EGB, polar desolvation energy, ESURF, non-
polar solvation energy) for the interaction of NIF with βCD and βCD:Asp systems, 
respectively. 
 
System VDW EEL EGB ESURF ΔE global 
NIF:β-CD -29.0 (±3.2) -5.5(±1.3) 19.5 (±4.5) -3.7 (±0.2) -18.7 (±3.3) 
NIF:β-CD:Asp -42.5 (±2.7) -24.2 (±5.6) 39.3 (±5.0) -4.6 (±0.1) -31.9 (±2.8) 
 
Table 3. Chemical shifts of protons of pure NIF, β-CD and Asp in free and complex form. 
NIF protons δ (ppm) δ (ppm) NIF:β-CD Δδ (ppm)a δ (ppm) NIF:β-CD:Asp Δδ (ppm)a 
Ha 9.0170 9.0170 0.0000 9.0140 -0.0030 
Hb 5.4900 5.4870 -0.0030 5.4840 -0.0060 













Hd 7.5910 7.5890 -0.0020 7.5900 -0.0010 
He 7.4550 7.4525 -0.0025 7.4530 -0.0020 
Hf 7.3500 7.3495 -0.0005 7.3490 -0.0010 
Hg 2.2490 2.470 -0.0020 2.2460 -0.0030 
Hh 3.4490 3.4470 -0.0020 3.4470 -0.0020 
β-CDprotons δ (ppm) δ (ppm) NIF:β-CD Δδ (ppm)a δ (ppm) NIF:β-CD:Asp Δδ (ppm)a 
H1 4.8240 4.8260 0.0020 4.8265 0.0025 
H2 3.2980 3.2980 0.0000 3.3010 0.0030 
OH2 5.7215 5.7370 0.0155 5.7345 0.0130 
H3 3.6280 3.6300 0.0020 3.6320 0.0040 
OH3 5.6700 5.6825 0.0125 5.6830 0.0130 
H4 3.2750 3.2775 0.0025 3.2760 0.0010 
H5 3.5575 3.5585 0.0010 3.5595 0.0020 
H6 3.6280 3.6300 0.0020 3.6320 0.0040 
OH6 4.4500 4.4630 0.0130 4.4600 0.1000 
ASP protons δ (ppm) δ (ppm) NIF:β-CD Δδ (ppm)a δ (ppm) NIF:β-CD:Asp Δδ (ppm)a 
HI 3.7795 - - 3.7790 -0.0005 
HII’ 2.7150 - - 2.7170 0.0020 
HII’’ 2.3830 - - 2.3905 0.0075 
 
 
Table 4. Wavenumbers (cm-1) of NIF pure, binary and multicomponent systems. 
Assignment NIF NIF:β-CDPM NIF:β-CDKN NIF:β-CD:AspPM NIF:β-CD:AspKN 
NH arom 3330 3331 3332 3331 3333 
NO2 1529 1529 1531 1529 1530 
C=C arom 1495 1495 1498 1495 1498 
C-C-O ester 1227 1227 1229 1227 1229 
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